Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -19.38M
March 31, 2026 -0.564M
December 31, 2025 144.43M
September 30, 2025 -145.16M
June 30, 2025 0.034M
March 31, 2025 -0.31M
December 31, 2024 0.127M
September 30, 2024 -0.873M
June 30, 2024 0.16M
March 31, 2024 -132.86M
December 31, 2023 0.21M
September 30, 2023 -6.158M
June 30, 2023 -0.749M
March 31, 2023 -1.054M
December 31, 2022 -0.043M
September 30, 2022 -2.037M
June 30, 2022 -1.507M
March 31, 2022 -0.959M
December 31, 2021 -0.985M
September 30, 2021 -2.87M
June 30, 2021 -0.147M
March 31, 2021 -218.11M
December 31, 2020 -1.376M
September 30, 2020 -1.46M
Date Value
June 30, 2020 -1.825M
March 31, 2020 -2.761M
December 31, 2019 -1.549M
September 30, 2019 -1.333M
June 30, 2019 -1.367M
March 31, 2019 -4.127M
December 31, 2018 -5.288M
September 30, 2018 -191.81M
June 30, 2018 -3.175M
March 31, 2018 -4.166M
December 31, 2017 -1.741M
September 30, 2017 -0.606M
June 30, 2017 -10.73M
March 31, 2017 -71.52M
December 31, 2016 0.055M
September 30, 2016 -0.044M
June 30, 2016 -0.109M
March 31, 2016 -0.021M
December 31, 2015 2.424M
September 30, 2015 -147.65M
June 30, 2015 -68.06M
March 31, 2015 -26.03M
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 9.00M
Capricor Therapeutics, Inc. -2.097M
Biogen, Inc. -6.00M
United Therapeutics Corp. -126.30M
Ardelyx, Inc. -1.68M